Zobrazeno 1 - 10 of 190 pro vyhledávání: '"GD Valk"'
2
Life-threatening complications of ibogaine: three case reports
Autor: Fp, Paling, Louise Andrews, Gd, Valk, Hj, Blom
Publikováno v: Europe PubMed Central
Ibogaine is a naturally occurring psychoactive alkaloid extracted from the roots of the Tabernanthe iboga plant, which in alternative medicine is used to treat drug dependency. However, this upcoming, online advocated therapy can be dangerous due to
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::1ab36a2643091f99bfabac3b8b5e4f0a
https://pubmed.ncbi.nlm.nih.gov/23123541
Zobrazit plný text záznamu
5
Akademický článek
Glucagon-Producing Pancreatic Neuroendocrine Tumors (Glucagonomas) are Enriched in Aggressive Neoplasms with ARX and PDX1 Co-expression, DAXX/ATRX Mutations, and ALT (Alternative Lengthening of Telomeres).
Autor: Mattiolo P; Department of Diagnostics and Public Health, Section of Pathology, University of Verona, Piazzale L.A. Scuro, 10, 37134, Verona, Italy., Bevere M; ARC-NET Applied Research On Cancer Center, University of Verona, Verona, Italy., Mafficini A; ARC-NET Applied Research On Cancer Center, University of Verona, Verona, Italy.; Department of Engineering for Innovation Medicine (DIMI), University of Verona, Verona, Italy., Verschuur AVD; Department of Pathology, UMC Utrecht, Utrecht, the Netherlands., Calicchia M; ARC-NET Applied Research On Cancer Center, University of Verona, Verona, Italy., Hackeng WM; Department of Pathology, UMC Utrecht, Utrecht, the Netherlands., Simbolo M; Department of Diagnostics and Public Health, Section of Pathology, University of Verona, Piazzale L.A. Scuro, 10, 37134, Verona, Italy., Paiella S; Department of General and Pancreatic Surgery, The Pancreas Institute, University and Hospital Trust of Verona, Verona, Italy., Dreijerink KMA; Department of Endocrinology, Amsterdam UMC, Amsterdam, the Netherlands.; Department of Pathology, UMC Utrecht, Utrecht, the Netherlands., Landoni L; Department of General and Pancreatic Surgery, The Pancreas Institute, University and Hospital Trust of Verona, Verona, Italy., Pedron S; Department of Diagnostics and Public Health, Section of Pathology, University of Verona, Piazzale L.A. Scuro, 10, 37134, Verona, Italy., Cingarlini S; Unit of Oncology, University and Hospital Trust of Verona, Verona, Italy., Salvia R; Department of General and Pancreatic Surgery, The Pancreas Institute, University and Hospital Trust of Verona, Verona, Italy., Milella M; Department of Engineering for Innovation Medicine (DIMI), University of Verona, Verona, Italy.; Unit of Oncology, University and Hospital Trust of Verona, Verona, Italy., Lawlor RT; ARC-NET Applied Research On Cancer Center, University of Verona, Verona, Italy.; Department of Engineering for Innovation Medicine (DIMI), University of Verona, Verona, Italy., Valk GD; Department of Endocrine Oncology, UMC Utrecht, Utrecht, the Netherlands., Vriens MR; Department of Endocrine Surgery, UMC Utrecht, Utrecht, the Netherlands., Scarpa A; Department of Diagnostics and Public Health, Section of Pathology, University of Verona, Piazzale L.A. Scuro, 10, 37134, Verona, Italy. aldo.scarpa@univr.it.; ARC-NET Applied Research On Cancer Center, University of Verona, Verona, Italy. aldo.scarpa@univr.it., Brosens LA; Department of Pathology, UMC Utrecht, Utrecht, the Netherlands. l.a.a.brosens@umcutrecht.nl.; Department of Pathology, Radboud University Medical Center, Nijmegen, The Netherlands. l.a.a.brosens@umcutrecht.nl., Luchini C; Department of Diagnostics and Public Health, Section of Pathology, University of Verona, Piazzale L.A. Scuro, 10, 37134, Verona, Italy. claudio.luchini@univr.it.; ARC-NET Applied Research On Cancer Center, University of Verona, Verona, Italy. claudio.luchini@univr.it.
Publikováno v: Endocrine pathology [Endocr Pathol] 2024 Sep 27. Date of Electronic Publication: 2024 Sep 27.
Zobrazit plný text záznamu
6
Akademický článek
Differences in checkpoint-inhibitor-induced hypophysitis: mono- versus combination therapy induced hypophysitis.
Autor: van der Leij S; Department of Endocrinology, University Medical Center, Utrecht University, Utrecht, Netherlands.; Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands., Suijkerbuijk KPM; Department of Medical Oncology, University Medical Center, Utrecht University, Utrecht, Netherlands., van den Broek MFM; Department of Endocrinology, University Medical Center, Utrecht University, Utrecht, Netherlands.; Department of Medical Oncology, University Medical Center, Utrecht University, Utrecht, Netherlands., Valk GD; Department of Endocrinology, University Medical Center, Utrecht University, Utrecht, Netherlands.; Department of Medical Oncology, University Medical Center, Utrecht University, Utrecht, Netherlands., Dankbaar JW; Department of Radiology, University Medical Center, Utrecht University, Utrecht, Netherlands., van Santen HM; Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands.; Department of Pediatric Endocrinology, Wilhelmina Children's Hospital, University Medical Center, Utrecht University, Utrecht, Netherlands.
Publikováno v: Frontiers in endocrinology [Front Endocrinol (Lausanne)] 2024 Jul 29; Vol. 15, pp. 1400841. Date of Electronic Publication: 2024 Jul 29 (Print Publication: 2024).
Zobrazit plný text záznamu
7
Akademický článek
Lived experiences of undergoing regular tumor screening in patients with multiple endocrine neoplasia types 1 and 2 (MEN1/MEN2).
Autor: Klein Haneveld MJ; Department of Endocrine Oncology, University Medical Center Utrecht, Utrecht, The Netherlands.; Emma Children's Hospital, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands., Valk GD; Department of Endocrine Oncology, University Medical Center Utrecht, Utrecht, The Netherlands., van Leeuwaarde RS; Department of Endocrine Oncology, University Medical Center Utrecht, Utrecht, The Netherlands.
Publikováno v: Journal of genetic counseling [J Genet Couns] 2024 Apr; Vol. 33 (2), pp. 402-412. Date of Electronic Publication: 2023 Jun 26.
Zobrazit plný text záznamu
8
Akademický článek
Expression of integrin α v β 3 in medullary thyroid carcinoma.
Autor: de Vries LH; Department of Surgery, University Medical Center Utrecht, Heidelberglaan 100, 3584, CX Utrecht, The Netherlands., Lodewijk L; Department of Surgery, University Medical Center Utrecht, Heidelberglaan 100, 3584, CX Utrecht, The Netherlands., Pijnappel EW; Department of Pathology, University Medical Center Utrecht, Heidelberglaan 100, 3584, CX Utrecht, The Netherlands., van Diest PJ; Department of Pathology, University Medical Center Utrecht, Heidelberglaan 100, 3584, CX Utrecht, The Netherlands., Schepers A; Department of Surgery, Leiden University Medical Center, Albinusdreef 2, 2333, ZA Leiden, The Netherlands., Bonenkamp HJ; Department of Surgery, Radboud University Medical Center, Geert Grooteplein 8, 6525, GA Nijmegen, The Netherlands., van Engen-van Grunsven IA; Department of Pathology, Radboud University Medical Center, Geert Grooteplein 8, 6525, GA Nijmegen, The Netherlands., Kruijff S; Department of Surgery, University Medical Center Groningen, Hanzeplein 1, 9700, RB Groningen, The Netherlands., van Hemel BM; Department of Pathology, University Medical Center Groningen, Hanzeplein 1, 9700, RB Groningen, The Netherlands., Links TP; Department of Internal Medicine, University Medical Center Groningen, Hanzeplein 1, 9700. RB Groningen, The Netherlands., Nieveen van Dijkum EJ; Department of Surgery, Amsterdam University Medical Center, location University of Amsterdam, Cancer Center Amsterdam, Meibergdreef 9, 1105, AZ Amsterdam, The Netherlands., van Eeden S; Department of Pathology, Amsterdam University Medical Center, location University of Amsterdam, Cancer Center Amsterdam, Meibergdreef 9, 1105, AZ Amsterdam, The Netherlands., van Leeuwaarde RS; Department of Endocrine Oncology, University Medical Center Utrecht, Heidelberglaan 100, 3584, CX Utrecht, The Netherlands., Valk GD; Department of Endocrine Oncology, University Medical Center Utrecht, Heidelberglaan 100, 3584, CX Utrecht, The Netherlands., de Keizer B; Department of Radiology & Nuclear Medicine, University Medical Center Utrecht, Heidelberglaan 100, 3584, CX Utrecht, The Netherlands., Borel Rinkes IH; Department of Surgery, University Medical Center Utrecht, Heidelberglaan 100, 3584, CX Utrecht, The Netherlands., Vriens MR; Department of Surgery, University Medical Center Utrecht, Heidelberglaan 100, 3584, CX Utrecht, The Netherlands.
Publikováno v: Future oncology (London, England) [Future Oncol] 2024; Vol. 20 (27), pp. 2015-2022. Date of Electronic Publication: 2024 Aug 05.
Zobrazit plný text záznamu
9
Akademický článek
Druggable growth dependencies and tumor evolution analysis in patient-derived organoids of neuroendocrine neoplasms from multiple body sites.
Autor: Dayton TL; Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences (KNAW) and UMC Utrecht, 3584 CT Utrecht, the Netherlands; Oncode Institute, Hubrecht Institute, 3584 CT Utrecht, the Netherlands. Electronic address: talya.dayton@embl.es., Alcala N; Rare Cancers Genomics Team (RCG), Genomic Epidemiology Branch (GEM), International Agency for Research on Cancer/World Health Organisation (IARC/WHO), 69007 Lyon, France., Moonen L; Department of Pathology, GROW School for Oncology and Reproduction, Maastricht University Medical Centre, 6229 ER Maastricht, the Netherlands., den Hartigh L; Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences (KNAW) and UMC Utrecht, 3584 CT Utrecht, the Netherlands., Geurts V; Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences (KNAW) and UMC Utrecht, 3584 CT Utrecht, the Netherlands., Mangiante L; Rare Cancers Genomics Team (RCG), Genomic Epidemiology Branch (GEM), International Agency for Research on Cancer/World Health Organisation (IARC/WHO), 69007 Lyon, France., Lap L; Department of Pathology, GROW School for Oncology and Reproduction, Maastricht University Medical Centre, 6229 ER Maastricht, the Netherlands., Dost AFM; Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences (KNAW) and UMC Utrecht, 3584 CT Utrecht, the Netherlands; Oncode Institute, Hubrecht Institute, 3584 CT Utrecht, the Netherlands., Beumer J; Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences (KNAW) and UMC Utrecht, 3584 CT Utrecht, the Netherlands; Oncode Institute, Hubrecht Institute, 3584 CT Utrecht, the Netherlands., Levy S; Department of Medical Oncology, Netherlands Cancer Institute, 1066 CX Amsterdam, the Netherlands., van Leeuwaarde RS; Department of Endocrine Oncology, University Medical Center Utrecht, 3584 CX Utrecht, the Netherlands., Hackeng WM; Department of Pathology, University Medical Center Utrecht, Utrecht University, 3584 CX Utrecht, the Netherlands., Samsom K; Department of Pathology, Netherlands Cancer Institute, Amsterdam 1066 CX, the Netherlands., Voegele C; Rare Cancers Genomics Team (RCG), Genomic Epidemiology Branch (GEM), International Agency for Research on Cancer/World Health Organisation (IARC/WHO), 69007 Lyon, France., Sexton-Oates A; Rare Cancers Genomics Team (RCG), Genomic Epidemiology Branch (GEM), International Agency for Research on Cancer/World Health Organisation (IARC/WHO), 69007 Lyon, France., Begthel H; Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences (KNAW) and UMC Utrecht, 3584 CT Utrecht, the Netherlands., Korving J; Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences (KNAW) and UMC Utrecht, 3584 CT Utrecht, the Netherlands., Hillen L; Department of Pathology, GROW School for Oncology and Reproduction, Maastricht University Medical Centre, 6229 ER Maastricht, the Netherlands., Brosens LAA; Department of Pathology, University Medical Center Utrecht, Utrecht University, 3584 CX Utrecht, the Netherlands., Lantuejoul S; Department of Biopathology, Pathology Research Platform- Synergie Lyon Cancer- CRCL, Centre Léon Bérard Unicancer, 69008 Lyon, France; Université Grenoble Alpes, Grenoble, France., Jaksani S; Hubrecht Organoid Technology, Utrecht 3584 CM, the Netherlands., Kok NFM; Department of Surgery, Netherlands Cancer Institute, Amsterdam 1066 CX, the Netherlands., Hartemink KJ; Department of Surgery, Netherlands Cancer Institute, Amsterdam 1066 CX, the Netherlands., Klomp HM; Department of Surgery, Netherlands Cancer Institute, Amsterdam 1066 CX, the Netherlands., Borel Rinkes IHM; Department of Endocrine Surgical Oncology, University Medical Center Utrecht, Utrecht 3508 GA, the Netherlands., Dingemans AM; Department of Pulmonary Diseases, GROW School for Oncology and and Reproduction, Maastricht University Medical Centre, Maastricht, the Netherlands; Department of Pulmonary Medicine, Erasmus MC Cancer Institute, University Medical Center, Rotterdam 3015 GD, the Netherlands., Valk GD; Department of Endocrine Oncology, University Medical Center Utrecht, 3584 CX Utrecht, the Netherlands., Vriens MR; Department of Endocrine Surgical Oncology, University Medical Center Utrecht, Utrecht 3508 GA, the Netherlands., Buikhuisen W; Department of Thoracic Oncology, Netherlands Cancer Institute, Amsterdam 1066 CX, the Netherlands., van den Berg J; Department of Pathology, Netherlands Cancer Institute, Amsterdam 1066 CX, the Netherlands., Tesselaar M; Department of Medical Oncology, Netherlands Cancer Institute, 1066 CX Amsterdam, the Netherlands., Derks J; Department of Pulmonary Diseases, GROW School for Oncology and and Reproduction, Maastricht University Medical Centre, Maastricht, the Netherlands., Speel EJ; Department of Pathology, GROW School for Oncology and Reproduction, Maastricht University Medical Centre, 6229 ER Maastricht, the Netherlands., Foll M; Rare Cancers Genomics Team (RCG), Genomic Epidemiology Branch (GEM), International Agency for Research on Cancer/World Health Organisation (IARC/WHO), 69007 Lyon, France., Fernández-Cuesta L; Rare Cancers Genomics Team (RCG), Genomic Epidemiology Branch (GEM), International Agency for Research on Cancer/World Health Organisation (IARC/WHO), 69007 Lyon, France. Electronic address: fernandezcuestal@iarc.who.int., Clevers H; Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences (KNAW) and UMC Utrecht, 3584 CT Utrecht, the Netherlands; Oncode Institute, Hubrecht Institute, 3584 CT Utrecht, the Netherlands. Electronic address: h.clevers@hubrecht.eu.
Publikováno v: Cancer cell [Cancer Cell] 2023 Dec 11; Vol. 41 (12), pp. 2083-2099.e9.
Zobrazit plný text záznamu
10
Akademický článek
Blood-based Proteomic Signatures Associated With MEN1-related Duodenopancreatic Neuroendocrine Tumor Progression.
Autor: Fahrmann JF; Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Wasylishen AR; Department of Genetics, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Department of Cancer Biology, University of Cincinnati, Cincinnati, OH 45267, USA., Pieterman CRC; Department of Surgical Oncology, Section of Surgical Endocrinology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Department of Endocrine Oncology, University Medical Center Utrecht, Utrecht 3508 GA, the Netherlands., Irajizad E; Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Vykoukal J; Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Wu R; Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Dennison JB; Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Peterson CB; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Zhao H; Department of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Department of Family Medicine and Population Health, Virginia Commonwealth University, Richmond, VA 23284, USA., Do KA; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Halperin DM; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Agarwal SK; Metabolic Diseases Branch, The National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD 20892, USA., Blau JE; Metabolic Diseases Branch, The National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD 20892, USA., Jha S; Metabolic Diseases Branch, The National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD 20892, USA., Rivero JD; Developmental Therapeutics Branch, The National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA., Nilubol N; Surgical Oncology Program, The National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA., Walter MF; Core for Clinical Laboratory Services, The National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD 20892, USA., Welch JM; Metabolic Diseases Branch, The National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD 20892, USA., Weinstein LS; Metabolic Diseases Branch, The National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD 20892, USA., Vriens MR; Department of Surgical Oncology and Endocrine Surgery, University Medical Center Utrecht, Utrecht 3584 CX, the Netherlands.; Center for Neuroendocrine Tumors, ENETS Center of Excellence, Netherlands Cancer Institute Amsterdam, University Medical Center Utrecht, Utrect 1066 CX, the Netherlands., van Leeuwaarde RS; Center for Neuroendocrine Tumors, ENETS Center of Excellence, Netherlands Cancer Institute Amsterdam, University Medical Center Utrecht, Utrect 1066 CX, the Netherlands.; Department of Cancer Biology, University of Cincinnati, Cincinnati, OH 45267, USA., van Treijen MJC; Center for Neuroendocrine Tumors, ENETS Center of Excellence, Netherlands Cancer Institute Amsterdam, University Medical Center Utrecht, Utrect 1066 CX, the Netherlands.; Department of Cancer Biology, University of Cincinnati, Cincinnati, OH 45267, USA., Valk GD; Center for Neuroendocrine Tumors, ENETS Center of Excellence, Netherlands Cancer Institute Amsterdam, University Medical Center Utrecht, Utrect 1066 CX, the Netherlands.; Department of Cancer Biology, University of Cincinnati, Cincinnati, OH 45267, USA., Perrier ND; Department of Surgical Oncology, Section of Surgical Endocrinology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Hanash SM; Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Katayama H; Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Publikováno v: The Journal of clinical endocrinology and metabolism [J Clin Endocrinol Metab] 2023 Nov 17; Vol. 108 (12), pp. 3260-3271.
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje